Robert A. Mantei

1.1k total citations
24 papers, 621 citations indexed

About

Robert A. Mantei is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert A. Mantei has authored 24 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert A. Mantei's work include Renin-Angiotensin System Studies (8 papers), Peptidase Inhibition and Analysis (5 papers) and Receptor Mechanisms and Signaling (5 papers). Robert A. Mantei is often cited by papers focused on Renin-Angiotensin System Studies (8 papers), Peptidase Inhibition and Analysis (5 papers) and Receptor Mechanisms and Signaling (5 papers). Robert A. Mantei collaborates with scholars based in United States and United Kingdom. Robert A. Mantei's co-authors include Steven A. Boyd, James M. Cook, Vered Klinghofer, Todd W. Rockway, Kent D. Stewart, William R. Baker, Vincent L. Giranda, V. Nienaber, Moshe Weitzberg and Michael Wendt and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Robert A. Mantei

24 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Mantei United States	15	308	258	111	95	76	24	621
Mark R. Witmer United States	16	378 1.2×	116 0.4×	104 0.9×	87 0.9×	59 0.8×	29	893
Carl P. Ciosek United States	18	545 1.8×	210 0.8×	126 1.1×	97 1.0×	36 0.5×	23	931
Ranjit C. Desai United States	14	352 1.1×	241 0.9×	130 1.2×	123 1.3×	61 0.8×	50	759
Aldo Balsamo Italy	18	258 0.8×	358 1.4×	148 1.3×	87 0.9×	65 0.9×	56	747
Ingo V. Hartung Germany	14	315 1.0×	477 1.8×	70 0.6×	56 0.6×	93 1.2×	36	906
Fumihiko Watanabe Japan	14	310 1.0×	381 1.5×	220 2.0×	203 2.1×	39 0.5×	35	860
S. Elaine Barrie United Kingdom	16	564 1.8×	122 0.5×	220 2.0×	216 2.3×	35 0.5×	25	1.3k
Ola Fjellström Sweden	20	550 1.8×	85 0.3×	60 0.5×	53 0.6×	43 0.6×	40	854
Leonard L. Winneroski United States	14	492 1.6×	399 1.5×	66 0.6×	42 0.4×	74 1.0×	22	901
Bernard D. Gary United States	20	749 2.4×	454 1.8×	200 1.8×	102 1.1×	47 0.6×	40	1.3k

Countries citing papers authored by Robert A. Mantei

Since Specialization

Citations

This map shows the geographic impact of Robert A. Mantei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Mantei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Mantei more than expected).

Fields of papers citing papers by Robert A. Mantei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Mantei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Mantei. The network helps show where Robert A. Mantei may publish in the future.

Co-authorship network of co-authors of Robert A. Mantei

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Mantei. A scholar is included among the top collaborators of Robert A. Mantei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Mantei. Robert A. Mantei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sorensen, Bryan K., Roberto M. Risi, Michael L. Curtin, et al.. (2023). Enabling, Decagram-Scale Synthesis of Macrocyclic MCL-1 Inhibitor ABBV-467. The Journal of Organic Chemistry. 88(22). 15562–15568. 3 indexed citations

Fidanze, Steve, Scott Erickson, Gary T. Wang, et al.. (2010). Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 20(8). 2452–2455. 50 indexed citations

Wang, Gary T., Robert A. Mantei, Robert D. Hubbard, et al.. (2010). Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases. Bioorganic & Medicinal Chemistry Letters. 20(20). 6067–6071. 22 indexed citations

Wang, Gary T., Robert A. Mantei, Megumi Kawai, et al.. (2007). Lead optimization of methionine aminopeptidase-2 (MetAP2) inhibitors containing sulfonamides of 5,6-disubstituted anthranilic acids. Bioorganic & Medicinal Chemistry Letters. 17(10). 2817–2822. 14 indexed citations

Wang, Gary T., Gaoquan Li, Robert A. Mantei, et al.. (2005). 1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyano- pyrazi-2-yl)ureas as Potent and Selective Inhibitors of Chk1 Kinase: Synthesis, Preliminary SAR, and Biological Activities. Journal of Medicinal Chemistry. 48(9). 3118–3121. 35 indexed citations

Wendt, Michael, William J. McClellan, Todd W. Rockway, et al.. (2004). Interaction with the S1β-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(12). 3063–3068. 24 indexed citations

Bruncko, Milan, William J. McClellan, Michael Wendt, et al.. (2004). Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 15(1). 93–98. 19 indexed citations

Hasvold, Lisa, Weibo Wang, Stephen L. Gwaltney, et al.. (2003). Pyridone-Containing farnesyltransferase inhibitors: synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 13(22). 4001–4005. 64 indexed citations

Wendt, Michael, Todd W. Rockway, William J. McClellan, et al.. (2003). Identification of Novel Binding Interactions in the Development of Potent, Selective 2-Naphthamidine Inhibitors of Urokinase. Synthesis, Structural Analysis, and SAR of N-Phenyl Amide 6-Substitution. Journal of Medicinal Chemistry. 47(2). 303–324. 58 indexed citations

10.

Nienaber, V., Donald J. Davidson, Rohinton Edalji, et al.. (2000). Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite. Structure. 8(5). 553–563. 46 indexed citations

11.

Boyd, Steven A., Robert A. Mantei, Andrew S. Tasker, et al.. (1999). Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ETA receptor selectivity. Bioorganic & Medicinal Chemistry. 7(6). 991–1002. 10 indexed citations

12.

Winn, Martin, Thomas W von Geldern, Terry J. Opgenorth, et al.. (1996). 2,4-Diarylpyrrolidine-3-carboxylic AcidsPotent ET_A Selective Endothelin Receptor Antagonists. 1. Discovery of A-127722. Journal of Medicinal Chemistry. 39(5). 1039–1048. 98 indexed citations

13.

Boyd, Steven A., Anthony K. L. Fung, William R. Baker, et al.. (1994). Nonpeptide Renin Inhibitors with Good Intraduodenal Bioavailability and Efficacy in Dog. Journal of Medicinal Chemistry. 37(19). 2991–3007. 29 indexed citations

14.

Zydowsky, Thomas M., Martin Winn, Biswanath De, et al.. (1994). Synthesis and In Vitro evaluation of fused ring heterocyle-containing angiotensin II antagonists.. Bioorganic & Medicinal Chemistry Letters. 4(1). 173–176. 5 indexed citations

15.

Wessale, Jerry L., Samuel V. Calzadilla, Steven A. Boyd, et al.. (1993). Cardiovascular Effects and Hemodynamic Mechanism of Action of the Novel, Nonpeptidic Renin Inhibitor A-74273 in Dogs. Journal of Cardiovascular Pharmacology. 22(4). 644–652. 8 indexed citations

16.

Verburg, Kenneth M., James S. Polakowski, Peter Kovar, et al.. (1993). Effects of High Doses of A-74273, a Novel Nonpeptidic and Orally Bioavailable Renin Inhibitor. Journal of Cardiovascular Pharmacology. 21(1). 149–155. 8 indexed citations

17.

Boyd, Steven A., Anthony K. L. Fung, William R. Baker, et al.. (1992). C-Terminal modifications of nonpeptide renin inhibitors: improved oral bioavailability via modification of physicochemical properties. Journal of Medicinal Chemistry. 35(10). 1735–1746. 27 indexed citations

18.

Stein, Herman H., Anthony K. L. Fung, Jerome Cohen, et al.. (1992). Slow, tight binding to human renin of some nonpeptidic renin inhibitors containing a 4‐methoxymethoxypiperidinylamide at the P4 position. FEBS Letters. 300(3). 301–304. 9 indexed citations

19.

Mantei, Robert A., et al.. (1982). Dichlorodicyanoquinone oxidations in the indole area. Synthesis of crenatine. The Journal of Organic Chemistry. 47(25). 4933–4936. 36 indexed citations

20.

Mantei, Robert A., et al.. (1980). ChemInform Abstract: SELENIUM DIOXIDE OXIDATIONS IN THE β‐CARBOLINE AREA. Chemischer Informationsdienst. 11(52). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact